Dronedarone: Drondarone, SR 33589, SR 33589B

Drugs in R and D

Volumn 8, Issue 3, 2007, Pages 171-175

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALMOKALANT; AMIODARONE; CAPTOPRIL; DIGOXIN; DILTIAZEM; DRONEDARONE; LIDOCAINE; NIFEDIPINE; PLACEBO; PROPRANOLOL; QUINIDINE; SOTALOL; SR 33589B; TICLOPIDINE; UNCLASSIFIED DRUG; VERAPAMIL; WARFARIN;

CARDIOVERSION; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG WITHDRAWAL; FOLLOW UP; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INFARCTION; HEART PROARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK BENEFIT ANALYSIS; SINUS RHYTHM; TORSADE DES POINTES; UNSPECIFIED SIDE EFFECT;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CLINICAL TRIALS; DRUG INTERACTIONS; HUMANS; POTASSIUM CHANNEL BLOCKERS;

EID: 34248189161     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200708030-00004     Document Type: Review

References (22)

1. sanofi-aventis. Sanofi-aventis receives a non approvable letter from the FDA for dronedarone (MULTAQ(tm)) in the treatment of Atrial Fibrillation/Atrial Flutter. Media Release: 31 Aug 2006. Available from URL: http://www.sanofi- aventis.com
2. sanofi-aventis. Analysis From Several Clinical Studies Show Dronedarone Appears to Be Consistently Safe and Effective in Maintaining Normal Sinusal Rhythm and Ventricular Rate Control in Patients With Cardiac Arrhythmia. Media Release: 15 Nov 2005. Available from URL: http://www.sanofi-aventis.com
3. Touboul P, Brugada J, Capucci A, et al. Dronedarone for prevention of atrial fibrillation: a dose-ranging study. European Heart Journal 24: 1481-1487, Aug 2003
4. Sanofi-Synthelabo. Sanofi-Synthelabo Outstanding 2003 Performance. Media Release: 16 Feb 2004. Available from URL: http://www.sanofi-synthelabo.com
5. European Society of Cardiology. ESC Congress 2004: Benefits of dronedarone in management of cardiac arrhythmia. Results of the EURIDIS trial announced at the European Society of Cardiology 2004 Congress. Media Release: 29 Aug 2004. Available from URL: http://www.eurekalert.org
6. Van Horn R, Brian W. Assessing the potential for co-administered drugs to inhibit the N-debutylation of SR 33589B using human liver microsomes. 7th North American ISSX Meeting 10: 393, 20 Oct 1996
7. Chen F, Sun W, Ding S, et al. Dronedarone alters calcium current kinetics in isolated mouse ventricular myocytes. Pediatric Research 47 (Suppl.): 39, Part 2, Apr 2000
8. Sun W, Sarma JSM, Ding S, et al. Dronedarone acutely inhibits L-type calcium currents and alters the channel kinetics in rabbit ventricular myocytes. Journal of the American College of Cardiology 37 (Suppl. A): 114, Feb 2001
9. Chatelain P, Meysmans L, Matteazzi JR, et al. Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart. British Journal of Pharmacology 116: 1949-1956, Oct 1995
10. Varró A, Papp JG. The cellular cardiac electrophysiological effects of dronedarone, a new amiodarone like antiarrhythmic agent. Cardiovascular Drugs and Therapy 14: 200, Mar 2000
11. Guillemare E, Marion A, Nisato D, et al. Inhibitory effects of dronedarone on muscarinic K+ current in guinea pig atrial cells. Journal of Cardiovascular Pharmacology 36: 802-805, Dec 2000
12. Manning A, Hodeige D, Richard J. SR33589, a new amiodarone-like antiarrhythmic agent: electrophysiological effects in dogs. British Journal of Pharmacology 112 (Suppl.): abstr. 579P, Jul 1994
13. Manning AS, Bruyninckx C, Hodeige D. SR 33589: a new amiodarone-like antiarrhythmic agent. British Journal of Pharmacology 107 (Suppl.): 270, Dec 1992
14. Iacour C, Canals F, Galindo G, et al. Amiodarone and dronedarone exert a wide inhibition of the vasoconstrictive effect of various neurohormones. European Journal of Heart Failure 2 (Suppl. 2): 56, Jun 2000
15. Finance O, Manning AS, Chatelain P. SR 33589B, a new amiodarone-like agent: effect on ischaemia-induced ventricular arrhythmias in anaesthetized pigs. British Journal of Pharmacology 111 (Suppl.): abstr. 28P, Jan 1994
16. Manning AS, Bruyninckx C, Ramboux J, et al. SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. Journal of Cardiovascular Pharmacology 26: 453-461, Sep 1995
17. Finance O, Manning A, Chatelain P. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. Journal of Cardiovascular Pharmacology 26: 570-576, Oct 1995
18. Verduyn SC, Leunissen JD, Vos MA. Intravenous administration of an amiodarone like agent, dronedarone (SR33589), does not evoke but suppresses torsade de pointes arrhythmias. Circulation 94 (Suppl.): 745, 15 Oct 1996
19. Djandjighian L, Planchenault J, Finance O, et al. Hemodynamic and antiadrenergic effects of dronedarone and amiodarone in animals with a healed myocardial infarction. Journal of Cardiovascular Pharmacology 36: 376-383, Sep 2000
20. Sun W, Sarma JSM, Singh BN. Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone. Journal of Cardiovascular Pharmacology 39: 677-684, May 2002
21. European Society of Cardiology. ESC Congress 2004: Dronedarone is effective and well-tolerated in prevention of AF recurrence. Media Release: 29 Aug 2004. Available from URL: http://www.eurekalert.org
22. Connolly SJ, Roy D, EURIDIS and ADONIS Investigators. Randomized trials of dronedarone for maintenance of sinus rhythm in atrial fibrilation or flutter: EURIDIS and ADONIS. Canadian Journal of Cardiology 20 (Suppl. D): 197-198, Oct 2004